SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-022118
Filing Date
2020-02-14
Accepted
2020-02-14 19:01:50
Documents
1
Period of Report
2020-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 tm208156d2_form4.html 4  
1 FORM 4 tm208156d2_form4.xml 4 3419
  Complete submission text file 0001104659-20-022118.txt   4896
Mailing Address 10 HUDSON YARDS, 37TH FLOOR New York NY 10001
Business Address 10 HUDSON YARDS, 37TH FLOOR NEW YORK NY 10001 646-747-1000
INTERCEPT PHARMACEUTICALS, INC. (Issuer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O WARNER CHILCOTT CORPORATION 100 ENTERPRISE DRIVE ROCKAWAY NJ 07855
Business Address
Sullivan Ryan T (Reporting) CIK: 0001578823 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35668 | Film No.: 20622668